Neoadjuvant endocrine therapy: for whom, for how long? Fatima Cardoso Editorial 17 February 2012 Pages: 81 - 82
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research Susana Patricia EgusquiaguirreManuela IgartuaJosé Luis Pedraz Educational Series / Blue Series 17 February 2012 Pages: 83 - 93
Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations Bella PajaresEsperanza TorresEmilio Alba Educational Series / Red Series 17 February 2012 Pages: 94 - 101
Review of Chinese clinical trials on CIK cell treatment for malignancies Xiao-Dong LiBin XuChang-Ping Wu Review 17 February 2012 Pages: 102 - 108
Ten-year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma José Luis GuinotM. Isabel TortajadaLeoncio Arribas Research Articles 17 February 2012 Pages: 109 - 115
Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma Jing-Jing ZhangYi ZhuYi Miao Research Articles 17 February 2012 Pages: 116 - 124
Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer Antonio Llombart-CussacÁngel GuerreroVicente Guillem Porta Research Articles 17 February 2012 Pages: 125 - 131
Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer. A pilot prospective study Cristina Moretones AgutDavid LeónFerran Guedea Research Articles 17 February 2012 Pages: 132 - 137
Examination of Smad2 and Smad4 copy-number variations in skin cancers Yong ShaoJie ZhangBo Yu Research Articles 17 February 2012 Pages: 138 - 142
JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma Zhenbing YouDafu XuJingdong He Research Articles 17 February 2012 Pages: 143 - 149
Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy Lori E. LowesMichael LockTracy Sexton Research Articles 17 February 2012 Pages: 150 - 156
CYP2D6*4 allele and breast cancer risk: Is there any association? Ana Fernández-SantanderMiguel del Saz SánchezFernando Bandrés Moya Brief Research Articles 17 February 2012 Pages: 157 - 159
Spanish Society of Medical Oncology (SEOM) Cancer and Thrombosis Working Group Andrés J. Muñoz MartínVanesa Pachón OlmosJuan Jesús Cruz Hernández Correspondence 17 February 2012 Pages: 160 - 160